They now have a Dollars 1.3 price target on the stock. Different analysts and financial institutions use various valuation methods and consider different economic forces when deciding on a price target. ImmunoGen, Inc. (IMGN) now has a …
ImmunoGen, Inc.
Today, Cantor Fitzgerald reiterated its Hold rating on ImmunoGen (NASDAQ:IMGN) with a price target of $5.00. There are 1 sell rating, 4 hold ratings, 3 buy ratings on the stock. The current consensus rating on ImmunoGen (NASDAQ:IMGN) …
ImmunoGen, Inc.
Several brokerages recently issued reports on IMGN. Royal Bank of Canada set a $5.00 price target on shares of ImmunoGen and gave the stock a “hold” rating in a research report on Saturday, May 6th. Canaccord Genuity set a …
BNS4d
ImmunoGen, Inc.
Shares of ImmunoGen (NASDAQ: IMGN) are up 11.6% at 3:33 p.m. EDT on no apparent news ... When investing geniuses David and Tom Gardner have a stock
Airplane!
ImmunoGen (NASDAQ: IMGN) is up 10.6% at 1:19 p.m. EDT following last ... When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. …
ImmunoGen, Inc.
ImmunoGen, Inc.IMGN was a big mover last session, as the company saw its shares jump above 14% on the day. The upside took place after it released abstracts for the current year's American Society of Clinical Oncology (ASCO) …
The company is expecting revenue between $70 million and $75 million for the year. IMGN stock is trading at $4.11 for a gain of 101.5% year to date (YTD). Zynga stock is up 8% in early morning trading after posting its earnings report. The …